Cargando…
30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization
Pneumonia accounts for over 20% of deaths worldwide in children aged 1 to 5 years, disproportionately affecting lower- and middle-income countries. Effective, highly multivalent pneumococcal vaccines are available to decrease disease burden, with numerous new vaccines currently under development to...
Autores principales: | Hu, Tianjing, Miller, David F., Taylor, Amber W., Riley, Christine, McCormick, Caitlin, Thomas, Keely N., Gao, Rachel Y., Rowlen, Kathy L., Byrne, Emilia B., Kumar, Pardeep, Kim, Soo Kyung, Dawson, Erica D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693921/ https://www.ncbi.nlm.nih.gov/pubmed/36423058 http://dx.doi.org/10.3390/vaccines10111964 |
Ejemplares similares
-
VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen
por: Dawson, Erica D., et al.
Publicado: (2022) -
Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing
por: Gillis, Jacob H., et al.
Publicado: (2021) -
VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2018) -
Rapid Identity and Quantity CQA Test for Multivalent mRNA Drug Product Formulations
por: Gao, Rachel Y., et al.
Publicado: (2022) -
Multiplexed suspension array immunoassays for detection of antibodies to pneumococcal polysaccharide and conjugate vaccines
por: Dunbar, Sherry A.
Publicado: (2023)